Ercros, S.A. (BME:ECR)

Spain · Delayed Price · Currency is EUR

3.465

+0.005 (0.14%)

Jun 26, 2026, 5:35 PM CET

16.47% (1Y)

Market Cap	316.83M +13.1%
Revenue (ttm)	600.27M -9.6%
Net Income	-55.04M
EPS	-0.60
Shares Out	91.44M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	32,749
Open	3.465
Previous Close	3.460
Day's Range	3.460 - 3.480
52-Week Range	2.230 - 3.480
Beta	0.19
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Ercros

Ercros, S.A., together with its subsidiaries, manufactures and sells chemical and pharmaceutical products in Spain and internationally. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmaceuticals. The company offers ammonia, caustic soda and potash, chlorine chloroisocyanurates, dichloroethane, ercrosbio, hydrochloric acid, hydrogen peroxide, polyvinyl chloride, potassium carbonate, PVC compounds, sodium chlorate, sodium chlorite, sodium hypochlorite, sulfuric acid, and vinyl chloride. It also provides ... [Read more]

Industry Chemicals

Sector Materials

Founded 1817

Employees 1,329

Stock Exchange Madrid Stock Exchange

Ticker Symbol ECR

Full Company Profile

Financial Performance

In 2025, Ercros's revenue was 628.69 million, a decrease of -5.92% compared to the previous year's 668.22 million. Losses were -53.59 million, 359.7% more than in 2024.

Financial Statements